Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Expression of protein kinase C (PKC) isoenzymes was determined in paired samples of normal mucosa and colorectal cancer tissue from 13 patients. Total PKC activity in cancer tissue was significantly decreased compared to that in normal mucosa. Western blotting, using PKC isoenzyme‐specific antibodies, showed that two PKC isoenzymes, PKC β and PKC ϵ, were significantly decreased in cancer tissue. The level of PKC δ was increased in cancer tissue and the expression of PKC α and ζ was not altered significantly. Primary bile acids—cholic acid (CA) and chenodeoxycholic acid (CDCA)—and the principal secondary bile acids—deoxycholic acid (DCA), lithocholic acid (LCA) and ursodeoxycholic acid (UDCA)—were found to be potent and selective activators of partially purified PKC isoenzymes. PKC β I was the isoenzyme most effectively activated by secondary bile acids. Our data provide a model for the involvement of secondary bile acids in colorectal carcinogenesis through specific PKC isoenzyme modulation in colorectal mucosa. © 1995 Wiley‐Liss, Inc.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, the protein levels of PKC alpha, beta and epsilon were found to be downregulated in cancers such as colon cancer [115, 116].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [115]
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · cited 1×
“The genetic mutations associated with the initiation and progression of colorectal neoplasia are relatively well established, and acquisition of these multiple genetic mutations is thought to be sequential (Fearon and Vogelstein, 1990).”
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
Nishizuka, Y. (1992) · Science · doi:10.1126/science.1411571 · Cited by 4,472
Narisawa, T., Magadia, N. E., Weisburger, J. H., & Wynder, E. L. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.4.1093 · Cited by 703
Reddy, B. S., & Wynder, E. L. (1977) · Cancer · doi:10.1002/1097-0142(197706)39:6<2533::aid-cncr2820390634>3.0.co;2-x · Cited by 410 · cited 1×
“In some clinical studies, raised faecal bile acid excretions, and especially a raised proportion of secondary bile acids, have been reported in patients with adenomatous polyps and CRC (Reddy and Wynder, 1977; Imray et al., 1992).”
The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation
Clemens, M. J., Trayner, I., & Menaya, J. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.4.881 · Cited by 266
Functional consequences of engagement of the T cell receptor by low affinity ligands
Alexander, J., Snoke, K., Ruppert, J., Sidney, J., Wall, M., Southwood, S., Oseroff, C., Arrhenius, T., Gaeta, F. C., & Colón, S. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.1.1 · Cited by 171
Diet and Risk of Colorectal Adenomas: Macronutrients, Cholesterol, and Fiber
Sandler, R. S., Lyles, C. M., Peipins, L. A., McAuliffe, C. A., Woosley, J. T., & Kupper, L. L. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.884 · Cited by 156
Faecal unconjugated bile acids in patients with colorectal cancer or polyps.
Imray, C. H., Radley, S., Davis, A., Barker, G., Hendrickse, C. W., Donovan, I. A., Lawson, A. M., Baker, P. R., & Neoptolemos, J. P. (1992) · Gut · doi:10.1136/gut.33.9.1239 · Cited by 143
Self-citationMacfarlane, D. E., & Manzel, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41782-0 · Cited by 129 · cited 6×
“These cells do not growth arrest and differentiate when treated with TPA, a potent PKC activator.”
InfluentialKiley, S. C., Schaap, D., Parker, P. J., Hsieh, L., & Jaken, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55455-7 · Cited by 122
Research works printed but not linked: 1
- Bradshaw T., 1992, Phorbol ester binding in colorectal cancer and the influence of bile acids, Brit. J. Cancer, 65, 30
Cited by
Protein kinase C and other diacylglycerol effectors in cancer
Griner, E. M., & Kazanietz, M. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2110 · Cited by 978
Bile acids as regulatory molecules
Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., & Dent, P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900007-jlr200 · Cited by 694
Tung, B. Y., Emond, M. J., Haggitt, R. C., Bronner, M. P., Kimmey, M. B., Kowdley, K. V., & Brentnall, T. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00008 · Cited by 469
β-Catenin—A Linchpin in Colorectal Carcinogenesis?
Wong, N. A. C. S., & Pignatelli, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64856-0 · Cited by 341
Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor
Antal, C. E., Hudson, A. M., Kang, E., Zanca, C., Wirth, C., Stephenson, N. L., Trotter, E. W., Gallegos, L. L., Miller, C. J., Furnari, F. B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.001 · Cited by 330
“Total PKC activity was significantly lower in human colorectal cancers versus normal mucosa because of decreased PKCb and PKCd (Craven and DeRubertis, 1994) or PKCb and PKCε protein levels (Pongracz et al., 1995).”
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
“Additionally, the protein levels of PKC alpha, beta and epsilon were found to be downregulated in cancers such as colon cancer [115, 116].”
BackgroundWnt/Beta-Catenin/Tcf Signaling: A Critical Pathway in Gastrointestinal Tumorigenesis
Kolligs, F. T., Bommer, G., & Göke, B. (2002) · Digestion · doi:10.1159/000066755 · Cited by 311
“and intracellular PKC-βII levels are increased after exposure to secondary bile acids, which are thought to be carcinogenic to the colonic epithelium [”
BackgroundRegulation of translocator protein 18kDa (TSPO) expression in health and disease states☆
Batarseh, A., & Papadopoulos, V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.013 · Cited by 270
“…cancer ↑ (Han et al., 2003) ↓ (Fields and Gustafson, 2003; Griner and Kazanietz, 2007) ↑ (Corvinus et al., 2005) N/S Colorectal carcinoma ↑ (Han et al., 2003) ↓ (Pongracz et al., 1995) N/S △ (Dhillon et al., 2007) Prostate cancer ↑ (Han et al., 2003) ↑ (Gorin and Pan, 2009) ↑ (Bromberg,…”
Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression
Isakov, N. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.012 · Cited by 270
“For example, the expression of PKCβII in colon cancer, was found to increase [137, 138], remain unchanged [139, 140] or decrease [139, 141, 142], with no direct correlation to the disease stage or severity.”
BackgroundLazaridis, K. N., Pham, L., Tietz, P., Marinelli, R. A., deGroen, P. C., Levine, S., Dawson, P. A., & LaRusso, N. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119816 · Cited by 258
“Bile acids are known to activate protein kinase C in hepatocytes (37) and enterocytes (38), and to increase cytosolic free Mg(21) in hepatocytes (39).”
BackgroundPosttranslational control of HuR function
Grammatikakis, I., Abdelmohsen, K., & Gorospe, M. (2017) · WIREs RNA · doi:10.1002/wrna.1372 · Cited by 237
“Although PKCδ functions as a tumor suppressor,(81) its levels are high in colorectal cancer.(82) Indeed, HuR was constitutively phosphorylated at S318 in DLD-1 colon cancer cells and in colon cancer tissues, and HuR binding to mRNAs was inhibited upon pharmacological or RNAimediated PKC inhibition.”
BackgroundLi, Y., Tang, Z., Ye, S., Liu, B., Liu, Y., Chen, J., & Xue, Q. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-002-0396-4 · Cited by 233
“Moreover, PKC b was decreased in colon adenocarcinoma ( Pongracz et al. 1995 ) and prostate cancer (Cornford et al. 1999).”
BackgroundMartinez, J. D., Stratagoules, E. D., LaRue, J. M., Powell, A. A., Gause, P. R., Craven, M. T., Payne, C. M., Powell, M. B., Gerner, E. W., & Earnest, D. L. (1998) · Nutrition and Cancer · doi:10.1080/01635589809514689 · Cited by 205
Murray, N. R., Davidson, L. A., Chapkin, R. S., Clay Gustafson, W., Schattenberg, D. G., & Fields, A. P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.4.699 · Cited by 181
“First, secondary bile acids and fatty acids can directly activate PKC bII activity and stimulate cellular proliferation in the colonic epithelium (DeRubertis et al., 1984; Fitzer et al., 1987; Ward and O’Brian, 1988; Pongracz et al., 1995).”
BackgroundElevated protein kinase C betaII is an early promotive event in colon carcinogenesis.
Gökmen‐Polar, Y., Murray, N. R., Velasco, M. A. D., Gatalica, Z., & Fields, A. P. (2001) · PubMed · Cited by 180
The role of bile acids in carcinogenesis
Debruyne, P. R., Bruyneel, E. A., Li, X., Zimber, A., Gespach, C., & Mareel, M. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00195-6 · Cited by 167
Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy
Goossens, J., & Bailly, C. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107396 · Cited by 164
Effect of Colonic Bacterial Metabolites on Caco-2 Cell Paracellular Permeability In Vitro
Hughes, R., Kurth, M. J., McGilligan, V., McGlynn, H., & Rowland, I. (2008) · Nutrition and Cancer · doi:10.1080/01635580701649644 · Cited by 139
“It has been suggested that the tumor-promoting effect of secondary bile acids is due to PKC activation (39,40).”
BackgroundProtein Kinase C Isoenzyme Patterns Characteristically Modulated in Early Prostate Cancer
Cornford, P. A., Evans, J., Dodson, A. R., PARSONS, K. F., Woolfenden, A., Neoptolemos, J. P., & Foster, C. S. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65260-1 · Cited by 144
“Total PKC activity has been reported to be increased in carcinomas of breast(17) and lung(18) and reduced in colon adenocarcinoma.(19) Interest in the role of PKC in prostate cancer was stimulated when it was shown that PKC activity was vital for the growth of androgen-independent prostate cells(20) whereas in androge…”
BackgroundSelf-citationInterplay between bile acids and the gut microbiota promotes intestinal carcinogenesis
Wang, S., Dong, W., Liu, L., Xu, M., Wang, Y., Liu, T., Zhang, Y., Wang, B., & Cao, H. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.22999 · Cited by 139
Chen, J.-Y., Tang, Y.-A., Huang, S.-M., Juan, H., Wu, L., Sun, Y., Wang, S.-C., Wu, K.-W., Gopula, B., Chang, T.-T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1303 · Cited by 142
“ST3Gal IV can be phosphorylated by protein kinase C leading to its inactivation (42), and the protein kinase C can be activated by secondary bile acids such as lithocholic acid (43).”
BackgroundLithocholic acid binds TULP3 to activate sirtuins and AMPK to slow down ageing
Qu, Q., Chen, Y., Wang, Y., Wang, W., Long, S., Yang, H.-Y., Wu, J., Li, M., Tian, X., Wei, X., et al. (2024) · Nature · doi:10.1038/s41586-024-08348-2 · Cited by 141
Alpini, G., Ueno, Y., Glaser, S. S., Marzioni, M., Phinizy, J. L., Francis, H., & LeSage, G. (2001) · Hepatology · doi:10.1053/jhep.2001.28884 · Cited by 122
Evaluation of fecal mutagenicity and colorectal cancer risk
de Kok, T. M. C. M., & van Maanen, J. M. S. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00003-x · Cited by 136
Tauroursodeoxycholate (TUDCA), chemical chaperone, enhances function of islets by reducing ER stress
Lee, Y. Y., Hong, S. H., Lee, Y. J., Chung, S. S., Jung, H. S., Park, S. G., & Park, K. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.022 · Cited by 126
Protein kinase C as a tumor suppressor
Newton, A. C. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.017 · Cited by 105
Gordge, P. C., Hulme, M. J., CLEGG, R. A., & Miller, W. R. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00255-9 · Cited by 108
Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis.
Deacon, E. M., Pongracz, J. E., Griffiths, G., & Lord, J. M. (1997) · Molecular Pathology · doi:10.1136/mp.50.3.124 · Cited by 111
Self-citationOncogenic β-Catenin Signaling Networks in Colorectal Cancer
Fuchs, S. Y., Ougolkov, A. V., Spiegelman, V. S., & Minamoto, T. (2005) · Cell Cycle · doi:10.4161/cc.4.11.2129 · Cited by 125
Mutanen, M. L., Pajari, A., & Oikarinen, S. I. (2000) · Carcinogenesis · doi:10.1093/carcin/21.6.1167 · Cited by 99
Nepelska, M., Cultrone, A., Béguet-Crespel, F., Le Roux, K., Doré, J., Arulampalam, V., & Blottière, H. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052869 · Cited by 88
“As a conclusion, in our study, we addressed in vitro the relevance of interaction between butyrate and other SCFAs with activators of PKC, such as diacylglycerols or deoxycholate, normally present in the lumen of the colon [56], [57].”
BackgroundMahmoud, N. N. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.299 · Cited by 92
Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation
Milović, V., Teller, I. C., Faust, D., Caspary, W. F., & Stein, J. M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.0014-2972.2001.00938.x · Cited by 91
Crowley-Weber, C. L. (2002) · Carcinogenesis · doi:10.1093/carcin/23.12.2063 · Cited by 91
Rosignoli, P., Fabiani, R., Bartolomeo, A. D., Fuccelli, R., Pelli, M. A., & Morozzi, G. (2008) · European Journal of Nutrition · doi:10.1007/s00394-008-0725-8 · Cited by 101
“Bile acids are also able to promote cell proliferation by inducing proto-oncogenes, like c-fos and c-jun [44], and stimulating several signal transduction pathways by PKC activation [17, 30].”
BackgroundProtein Kinase C (PKC) Isozymes and Cancer
Kang, J. (2014) · New Journal of Science · doi:10.1155/2014/231418 · Cited by 106
“, deoxycholic acid, lithocholic acid, and ursodeoxycholic acid) in colon cancer tissues [104].”
BackgroundDebruyne, P. R., Bruyneel, E. A., Karaguni, I.-M., Li, X., Flatau, G., Müller, O., Zimber, A., Gespach, C. P., & Mareel, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205729 · Cited by 85
“Activation of PKC by BA is well-documented in colorectal cancer cells (Huang et al., 1992; Pongracz et al., 1995; Hirano et al., 1996; Rao et al., 1997; Qiao et al., 2000).”
BackgroundThe Role of Protein Kinase C Isoforms in Modulating Injury and Repair of the Intestinal Barrier
Farhadi, A., Keshavarzian, A., Ranjbaran, Z. S., Fields, J. Z., & Banan, A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085449 · Cited by 90
“(1995) found a lower amount of PKC- in cancer tissue than in controls (Pongracz et al., 1995).”
BackgroundInfluentialMühlbauer, M., Allard, B., Bosserhoff, A. K., Kiessling, S., Herfarth, H., Rogler, G., Schölmerich, J., Jobin, C., & Hellerbrand, C. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00338.2003 · Cited by 78
“BAs utilize multiple signaling cascades such as p53 (29), the mitogen-activated protein kinases ERK and p38 (28, 30), or PKC (27), phosphatidylinositol 3-kinase (PI3kinase) (36), and the activator protein-1 (AP-1) transcription factor (28) to modify gene expression.”
BackgroundAlteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma
Tsai, J.-H. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00597-8 · Cited by 79
“The decrease pattern in the PKC activity and protein in colonic cancers has been attributed to the continuous activation by secretory bile acids [17].”
BackgroundModulation of protein kinase C in antitumor treatment
Hofmann, J. (2008) · Springer eBooks · doi:10.1007/bfb0117491 · Cited by 79
Nguyen, T. T., Lian, S., Ung, T. T., Xia, Y., Han, J., & Jung, Y. D. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25955 · Cited by 76
“, 1987], activationofprotein kinaseC [Pongracz et al., 1995], and suppressionof HLA gene expression [Arvind et al.”
BackgroundCellular and Molecular Pathology of Prostate Cancer Precursors
Foster, C. S., Bostwick, D. G., Bonkhoff, H., Damber, J., van der Kwast, T., Montironi, R., & Sakr, W. A. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655900750169284 · Cited by 72
Alpini, G. D., Kanno, N., Phinizy, J. L., Glaser, S. S., Francis, H., Taffetani, S., & LeSage, G. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00270.2003 · Cited by 70
“The cAMP-dependent PKA-MEK-MAPK pathway is modulated via cross-talk with other intracellular signaling pathways (64), including PKC, which studies have shown to be associated with activation of MAPK (50).”
BackgroundBile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines
Tucker, O., Dannenberg, A. J., Yang, E. K., & Fahey, T. J. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh010 · Cited by 70
Histone Hyperacetylation Up-regulates Protein Kinase Cδ in Dopaminergic Neurons to Induce Cell Death
Jin, H., Kanthasamy, A., Harischandra, D. S., Kondru, N., Ghosh, A., Panicker, N., Anantharam, V., Rana, A., & Kanthasamy, A. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576702 · Cited by 68
Doller, A., Winkler, C., Azrilian, I., Schulz, S., Hartmann, S., Pfeilschifter, J. M., & Eberhardt, W. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr024 · Cited by 71
Ersvær, E., Kittang, A. O., Hampson, P., Sand, K. E., Gjertsen, B. T., Lord, J. M., & Bruserud, Ø. (2010) · Toxins · doi:10.3390/toxins2010174 · Cited by 66
Self-citationAllen-Petersen, B. L., Carter, C. J., Ohm, A. M., & Reyland, M. E. (2014) · Oncogene · doi:10.1038/onc.2013.59 · Cited by 53
Regulation of mdr2 P-glycoprotein expression by bile salts
Frijters, C. M. G., Ottenhoff, R., van Wijland, M. J. A., van Nieuwkerk, C. M. J., Groen, A. K., & Elferink, R. P. J. O. (1997) · Biochemical Journal · doi:10.1042/bj3210389 · Cited by 54
Awad, A. B., Hernandez, A. Y. T., Fink, C. S., & Mendel, S. L. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514527 · Cited by 51
Bile acids induce MUC2 overexpression in human colon carcinoma cells
Song, S., Byrd, J. C., Koo, J. S., & Bresalier, R. S. (2005) · Cancer · doi:10.1002/cncr.21015 · Cited by 51
“Activation of PKC by bile acids is well documented, and may be one mechanism of bile acidinduced carcinogenesis.(29,30) We found that the PKC inhibitor calphostin C strongly blocked c-jun/AP-1 and MUC2 induction by DCA, indicating that PKC is involved in the bile acid-dependent induction of MUC2.”
BackgroundDifferences in Ca2+ signaling underlie age-specific effects of secretagogues on colonic Cl−transport
Venkatasubramanian, J., Selvaraj, N. G., Carlos, M. I. R., Skaluba, S., Rasenick, M. M., & Rao, M. C. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.3.c646 · Cited by 50
McMillan, L., Butcher, S. K., Pongracz, J. E., & Lord, J. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600793 · Cited by 54
“While bile acids are not mutagenic, they have been shown to act as tumour promoters in animal studies (Narisawa et al, 1974; Mahmoud et al, 1999) and PKC has been identified as their molecular target (Pongracz et al, 1995).”
BackgroundSelf-citationBenhadji, K. A., Serova, M., Ghoul, A., Cvitkovic, E., Tourneau, C. L., Ogbourne, S. M., Lokiec, F. M., Calvo, F. M., Hammel, P. R., Faivre, S. J., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604642 · Cited by 46
“The expression of PKC isozymes in tumours has been shown to be partially tissue specific (Pongracz et al, 1995; Verstovsek et al, 1998; Griner and Kazanietz, 2007).”
BackgroundReview : Bile acids, fibre and colon cancer: the story unfolds
Chaplin, M. F. (1998) · Journal of the Royal Society of Health · doi:10.1177/146642409811800111 · Cited by 45
Wilson, A. J., & Gibson, P. R. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4496 · Cited by 44
McMillan, L., Butcher, S. K., Wallis, Y., Neoptolemos, J. P., & Lord, J. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2899 · Cited by 43
Self-citationHalvorsen, B. L., Staff, A. C., LIGAARDEN, S., Prydz, K., & Kolset, S. O. (2000) · Biochemical Journal · doi:10.1042/bj3490189 · Cited by 42
Deoxycholic acid stimulates migration in colon cancer cells
Milović, V., Teller, I. C., Murphy, G. M., Caspary, W. F., & Stein, J. M. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200108000-00012 · Cited by 41
Strauch, E. D., Yamaguchi, J., Bass, B. L., & Wang, J. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00720-8 · Cited by 42
Pysz, M. A., Leontieva, O. V., Bateman, N. W., Uronis, J. M., Curry, K., Threadgill, D. W., Janssen, K., Robine, S., Velcich, A., Augenlicht, L. H., et al. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.02.002 · Cited by 40
“PKCε protein showed variability in total levels and in the relative proportion of the two major species detected in CRC cells, consistent with discrepancies in the literature regarding its expression in primary colon tumors [30-32].”
ResultKnauf, J. A., Ward, L. S., Nikiforov, Y. E., Nikiforova, M. N., Puxeddu, E., Medvedovic, M., Liron, T., Mochly‐Rosen, D., & Fagin, J. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8441 · Cited by 41
Localized measurement of kinase activation in oocytes of Xenopus laevis
Lee, C.-L., Linton, J., Soughayer, J. S., Sims, C. E., & Allbritton, N. L. (1999) · Nature Biotechnology · doi:10.1038/11691 · Cited by 38
“To estimate how much phosphorylation might occur after the onset of electrophoresis, cholic acid (645 mg/ml), a potent activator of PKC, was added to the buffer in the capillary and reservoir”
Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats
Seraj, M. J., Umemoto, A., Kajikawa, A., Mimura, S., Kinouchi, T., Ohnishi, Y., & Monden, Y. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04719-8 · Cited by 38
Mucin secretion by the human colon cell line LS174T is regulated by bile salts
Klinkspoor, J. H., Mok, K. S., Van Klinken, B. J.-W., Tytgat, G. N. J., Lee, S. P., & Groen, A. K. (1999) · Glycobiology · doi:10.1093/glycob/9.1.13 · Cited by 38
“Both primary and secondary bile salts were found to be potent and selective activators of partially purified protein kinase C isoenzymes from normal colorectal mucosa (Pongracz et al., 1995).”
BackgroundActivation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes
Cullen, J. K., Boyle, G. M., Yap, P.-Y., Elmlinger, S., Simmons, J. L., Broit, N., Johns, J. P., Ferguson, B., Maslovskaya, L. A., Savchenko, A. I., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80397-9 · Cited by 35
Dyck, M. C., David, W. L., & Meckling, K. A. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.05.006 · Cited by 38
“Increasing PKC abundance can increase proliferative capacity in breast [111] and lung cancer [112] but it is decreased in colon cancer [113].”
BackgroundUrsodeoxycholic acid treatment in a rat model of cancer cachexia
Tschirner, A., von Haehling, S., Palus, S., Doehner, W., Anker, S. D., & Springer, J. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0044-4 · Cited by 35
“A possible mechanism explaining the anti-inflammatory and antiapoptotic effect could be that UDCA blocks the cancer induced generation of reactive oxygen species and subsequently inhibiting the transcription factors AP-1, and NF-κB important for carcinogenesis through the PKC signaling pathway, established from other…”
ResultPeiffer, L. P., Peters, D. J., & McGarrity, T. J. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018806431866 · Cited by 35
“Pongracz et al (25) noted that 10 m M DCA induced PKC activity in human normal and neoplastic tissue , and selective ly increased PKC b 1 expression ® ve fold compared to control.”
BackgroundNF-κB Regulates Intestinal Epithelial Cell and Bile Salt-Induced Migration After Injury
Strauch, E. D., Bass, B. L., Rao, J. N., Vann, J. A., & Wang, J. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000060459.03270.e7 · Cited by 36
Mustafi, R., Cerda, S., Chumsangsri, A., Fichera, A., & Bissonnette, M. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0057 · Cited by 34
“Results PKC-f Is Down-Regulated in Human Colonic Polyps and Colon Cancers We have previously shown that PKC-~ expression was decreased in azoxymethane-induced rat colonic tumors (4), but results in human colonic tumors have been conflicting (31-33).”
BackgroundResultRickard, K. L., Gibson, P. R., Young, G. P., & Phillips, W. A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.977 · Cited by 31
“Similarly, the bile salt deoxycholate, which has been demonstrated to activate PKC ( 33 ,34), also synergized with butyrate to enhance alkaline phosphatase activity.”
BackgroundThe Role of Protein Kinase C in Gastrointestinal Function and Disease
Mari, J. F. D., Mifflin, R. C., & Powell, D. W. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.09.078 · Cited by 28
Chemoprevention and screening in primary sclerosing cholangitis
Kitiyakara, T., & Chapman, R. W. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.064592 · Cited by 25
Arginase Activity Determination A Marker of Large Bowel Mucosa Proliferation
Kocna, P., Fric, P., Zavoral, M., & Pelech, T. (1996) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1996.34.8.619 · Cited by 24
Kajiura, K., Ohkusa, T., & Okayasu, I. (1998) · Digestion · doi:10.1159/000007469 · Cited by 24
Volak, L. P., & Court, M. H. (2010) · Xenobiotica · doi:10.3109/00498251003596817 · Cited by 24
“Several reports provide evidence that PKC α, β, δ, ε, η, and ζ, but not γ, θ, or μ are expressed in both normal colonic tissue and colon cancer cell lines (Caco-2 and LIM1215) (Abraham et al. 1998; Davidson et al. 1994; Doi et al. 1994; Pongracz et al. 1995; Rickard et al. 2000).”
Bile Acids in the Assessment of Hepatocellular Function
Thompson, M. B. (1996) · Toxicologic Pathology · doi:10.1177/019262339602400109 · Cited by 27
Mechanism of bile salt-induced mucin secretion by cultured dog gallbladder epithelial cells
Klinkspoor, J. H., Tytgat, G. N. J., LEE, S. P., & Groen, A. K. (1996) · Biochemical Journal · doi:10.1042/bj3160873 · Cited by 24
Pajari, A., Oikarinen, S. I., Gråsten, S. M., & Mutanen, M. L. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500001975 · Cited by 23
“expression have also been reported, so that most studies have shown reduced protein expression of one or more PKC isozymes in colon tumours when compared with the normal mucosa (Kahl-Rainer et al. 1994; Pongracz et al. 1995; Wali et al. 1995).”
BackgroundZhang, Y., Tang, N., Zhou, H., & Zhu, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116218 · Cited by 22
Omar, H. A., Zaher, D. M., Srinivasulu, V., Hersi, F., Tarazi, H., & Al‐Tel, T. H. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.054 · Cited by 22
Freund, E., Liedtke, K. R., Miebach, L., Wende, K., Heidecke, A., Kaushik, N. K., Choi, E. H., Partecke, L.-I., & Bekeschus, S. (2020) · Cancers · doi:10.3390/cancers12010122 · Cited by 22
“Here, somatic mutations of the enzyme have been observed with the δ isotype being upregulated compared to non-malignant tissue [47].”
BackgroundEffects of specific bile acids on c-fos messenger RNA levels in human colon carcinoma Caco-2 cells
Toro, R. D., Campana, G., Murari, G., & Spampinato, S. M. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00111-1 · Cited by 22
Gill, R. K., Alrefai, W. A., Borthakur, A., & Dudeja, P. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00067-1 · Cited by 21
Rickard, K. L., Gibson, P. R., Wilson, N. J., Mariadason, J. M., & Phillips, W. A. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200002)182:2<222::aid-jcp11>3.0.co;2-b · Cited by 21
Protein kinase C: a family of isoenzymes with distinct roles in pathogenesis
Lord, J. M., & Pongracz, J. E. (1995) · Molecular Pathology · doi:10.1136/mp.48.2.m57 · Cited by 21
Self-citationLate-Stage Glioma Is Associated with Deleterious Alteration of Gut Bacterial Metabolites in Mice
Herbreteau, A., Aubert, P., Croyal, M., Naveilhan, P., Billon‐Crossouard, S., Neunlist, M., Delneste, Y., Couez, D., & Aymeric, L. (2022) · Metabolites · doi:10.3390/metabo12040290 · Cited by 19
Ostrowski, J., Trzeciak, L., Kolodziejski, J., & Bomsztyk, K. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.675 · Cited by 20
Huerta, S., Irwin, R. W., Heber, D., Go, V. L. W., Moatamed, F., Huerta, S., Ou, C., & Harris, D. M. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1023083025595 · Cited by 18
“Additionally, bile acids can activate protein kinase C, an enzyme that plays a key role in signal transduction and tumor promotion by mediating the actions of certain growth factors, hormones, and tumor promoters (48, 49).”
BackgroundChemoprevention of colorectal cancer with ursodeoxycholic acid: Cons
Carey, E. J., & Lindor, K. D. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(12)70023-2 · Cited by 20
Li, S.-R., Gyselman, V. G., Lalude, O., Dorudi, S., & Bustin, S. A. (2000) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(200004)27:4<322::aid-mc10>3.0.co;2-c · Cited by 20
Emerging Targets of the GnRH Receptor: Novel Interactions with Wnt Signalling Mediators
Gardner, S., & Pawson, A. J. (2009) · Neuroendocrinology · doi:10.1159/000165377 · Cited by 16
“PKC and PKC have been demonstrated to have increased and decreased expression in colon cancer, respectively, and PKC has been implicated in the early stages of prostate cancer development [Pongracz et al., 1995; Cornford et al., 1999].”
BackgroundBile Salt Stimulates Intestinal Epithelial Cell Migration through TGFβ after Wounding
Strauch, E. D., Wang, J., & Bass, B. L. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6110 · Cited by 17
Fatty Acid Regulation of Protein Kinase C Isoforms in Prostate Cancer Cells
PANDIAN, S. S., Sneddon, A. A., Bestwick, C. S., McClinton, S., Grant, I., Wahle, K. W. J., & Heys, S. D. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4873 · Cited by 17
Farnesoid X receptor: Acting through bile acids to treat metabolic disorders
Zhang, Y. (2010) · Drugs of the Future · doi:10.1358/dof.2010.035.08.1520865 · Cited by 15
Hansen, M. E., & Matsumura, F. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00445-5 · Cited by 14
PKCβ: Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol
Mehta, D., & Mehta, K. D. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00373.2016 · Cited by 14
Metadata
- Authors
- Pongracz, J., Clark, P., Neoptolemos, J. P., & Lord, J. M.
- Affiliations
- University of Birmingham (GB)
- Corresponding author
- Pongracz, Judit
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1995-03-29
- Volume
- 61
- Issue
- 1
- Pages
- 35-39
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2035442827
- Cited by
- 137
- References
- 22
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 9 · 2021: 4 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 5 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 3
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- protein kinase C isoenzymes, colorectal cancer, protein kinase C epsilon, PKCδ, bile acids, secondary bile acids, cholic acid, chenodeoxycholic acid, deoxycholic acid, lithocholic acid, ursodeoxycholic acid, colorectal carcinogenesis, PKC activation
- MeSH terms
- Bile Acids and Salts, Colon, Enzyme Activation, Humans, Intestinal Mucosa, Isoenzymes, Protein Kinase C, Rectum, Colorectal Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.